Clinical Trials Browser

Recruiting × Carcinoma × Trastuzumab × Clear all

NCT04379596 2026-02-23

DG-03

Phase 2 Recruiting

Gastrointestinal

Adenocarcinoma, Carcinoma, Esophageal Neoplasms, Stomach Neoplasms